Two popular children’s cough medicines recalled due to overdose risk
Both children’s Robitussin Honey Cough and Chest Congestion DM along with Children’s Dimetapp cold and cough are being recalled due to potential overdose risks.
The GSK Consumer Healthcare company says the wrong sized dosing cups were put in the packages which could cause parents to put too much medicine in them.
The recall is limited to the three lots listed below:
- Children’s Robitussin® Honey Cough and Chest Congestion DM (4oz)
NDC 0031-8760-12
Lots: 02177 (Exp. Jan. 2022) and 02178 (Exp. Jan. 2022) - Children’s Dimetapp® Cold and Cough (8oz)
NDC 0031-2234-19
Lot: CL8292 (Exp. Sep. 2021)
These lots were distributed nationwide between February 5, 2020 and June 3, 2020 within the United States. GSK Consumer Healthcare has notified wholesalers, distributors and retailers to arrange for return of any recalled product, the FDA said.
If you bought either medicine and it matches the lot numbers above, you’re asked to throw it away.
